Business
NuGen Announces Repeat Order for Growing InsuJet(TM) Demand in Yemen
Toronto, Ontario--(Newsfile Corp. - June 28, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the...
About this update from Nugen Medical Devices Inc
[{"type":"text","content":"NuGen Announces Repeat Order for Growing InsuJet(TM) Demand in YemenToronto, Ontario--(Newsfile Corp. - June 28, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the \"Company\" or \"NuGen\") a leading developer of needle-free devices to administer therapeutics subcutaneously, is pleased to announce that Rosheta for Medicines and Medical Supplies (\"Rosheta\"), NuGen's exclusive distributor in Yemen, has placed a second order to fulfill growing demand in the country.The order includes 1,100 InsuJetTM units and associated consumables representing revenue of $147,000, and a gross margin contribution on the original sale of $102,900. Rosheta received an order from its clients for 800 InsuJetTM units for the product's initial launch in Yemen in January 2024. Given the strong demand for needle-free injectors across the country, Rosheta is now pursuing a Yemen-wide marketing plan. The current order of 1,100 units (37.5% increase over the initial order) is required to replenish the pharmacies currently distributing InsuJet™ but also to support the nationwide distribution expansion.NuGen's CEO, Ian Heynen commented: \"Dr. Al-Shami and the Rosheta team are pursuing a strong clinical marketing strategy in Yemen. They are successfully influencing adoption by patients and the healthcare system at the pharmacy and physician level. I would like to congratulate Rosheta on deepening their market penetration and we look forward to continued growth together.\"About NuGen:NuGen is a leading developer of needle-free devices to administer therapeutics subcutaneously. The Company is marketing and selling its next-generation InsuJet™ needle-free injection system designed to improve the lives of millions of diabetics. InsuJet™ is approved for sale in 42 countries around the world.For further information, please visit: Websites: www.insujet.com, www.nugenmd.com Instagram: @NuGenMDTwitter: @NuGenMDLinkedIn: https://www.linkedin.com/company/nugenmd/For further information, please contact:Tony Di BenedettoExecutive Chairman(416) [email protected] Heynen CEO(416) [email protected] arrange a media interview with NuGen, please contact:Morna Gorman(416) [email protected] Regarding Forward-Looking Information:Neither TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSX...